Sleep-disordered breathing (SDB) is frequently observed in patients with congestive heart failure. Recent studies have shown that SDB negatively affects the onset of congestive heart failure; however, no studies have addressed the relationship between the level of SDB and the onset time of acute dyspnea. We hypothesized that SDB affects the acute onset time of dyspnea (AOT) and investigated the relationship between SDB and AOT.
interval between breaths during sleep (7 hours) or at least 5 episodes of apnea or hypopnea per hour of sleep combined with symptoms, such as excessive daytime sleepiness. It is mainly divided into two types, obstructive sleep apnea syndrome (OSAS) and central sleep apnea syndrome (CSAS). Untreated SAS may be responsible for impairments in daily life, especially motor vehicle accidents. On the other hand, SAS or SDB has been recognized as one of the pathophysiological mechanisms of heart failure. The Sleep Heart Health Study 2001 in the United States 1) reported that OSAS patients are at 2.38 times higher risk for the onset of heart failure and OSAS is defined as an independent prognostic factor of heart failure. Sympathetic nerve activity is augmented and blood pressure is elevated gradually before waking up. In patients with SDB, the onset time of heart diseases is estimated to be between midnight and dawn. In 1995, Franklin, et al 2) reported that SDB might affect hypoxemia and ST changes, thus resulting in the onset of angina pectoris during the night. To date, no study has reported a relationship between SDB in patients with congestive heart failure and the acute onset time of heart failure. Angiotensin converting enzyme (ACE) inhibitors and β-blockers are generally administered to patients with heart failure. Recently, the prevention of heart failure has gained broad attention. If many patients with SDB suffer from heart failure between midnight and dawn, the development of an appropriate SDB treatment could possibly prevent such events. This study investigated the severity of apnea in patients with congestive heart failure and evaluated the relationship between SDB and acute onset time.
METHODS
Subjects: This retrospective study was conducted in 80 consecutive patients with congestive heart failure who were admitted to St. Marianna University School of Medicine Hospital, Kawasaki, Japan between May 2003 and April 2004 and who 1) were in class II to IV in the New York Heart Association functional classification at baseline, 2) had diffuse decreased left ventricular wall motion, 3) were treated with standard medical treatment, and 4) had no dyspnea, edema, medication change, drip infusion or oxygen administration for at least 1 week before enrollment. Patients in unstable condition, those with acute myocardial infarction within 3 months, unstable angina pectoris, severe renal or liver disease, cancer, a history of cerebral infarction or chronic obstructive pulmonary diseases and those who refused to undergo polysomnography were excluded. Measurements: Within one week before discharge, height and body weight were recorded, and brain natriuretic peptide (BNP) levels were measured by a fluorescent enzyme immunoassay (FEIA) method between 6:00 and 7:00 before breakfast. At the same time, the patients underwent standard M-mode . A thermistor and a nasal cannula were placed on the nostril and mouth to measure respiratory airflow, and a strain gauge sensor monitored respiratory movements of the chest and abdominal walls. Arterial oxygen saturation (SpO 2 ) was continuously measured via pulse oxymetry. Apnea was defined as continuous cessation of breathing airflow for 10 seconds or more per hour of sleep; hypopnea was defined based on the absence of both chest and abdominal wall movement and an airflow lasting at least 10 seconds, a reduction in breathing airflow of 30% or more of a normal breath with an EEG arousal response or 3% or more SpO 2 desaturation. Portable PSG included an oronasal thermistor, an impedance pneumograph to observe thoracoabdominal movements, ECG, and SpO 2 desaturation. Apnea was defined as a 10 second or more interval between nasal or mouth breath and hypopnea was defined, on the basis of the absence of both chest and abdominal wall movement and airflow lasting at least 10 seconds, as a reduction in the breathing airflow of 30% or more of a normal breath and 3% or more SpO 2 . The apnea-hypopnea index (AHI) was calculated as the total number of apnea and hypopnea events per hour of sleep. OSAS or CSAS was determined based on the presence of abdominal movement. Patients with 5 ≧ AHI were defined as having SDB and patients with 20 ≧ AHI were classified as having severe SDB. Analysis of onset time: Acute dyspnea was defined as dyspnea at rest or orthopnea. The acute onset time of dyspnea (AOT) was determined by a retrospective analysis based on clinical records. AOT was divided into 4 time periods; 0:00 -6:00, 6:00 -12:00, 12:00 -18:00, and 18:00 -24:00. In addition, patients who had no symptoms of dyspnea during examination or who had symptoms but could not identify the precise onset time were categorized as unknown. Therefore, AOT was divided into 5 periods in this study.
Statistical analysis:
The data are expressed as the mean ± standard deviation. Differences between groups were determined by analysis of variance (ANOVA) and the Bonfferoni correction was used for multiple comparisons. The unpaired t-test was used to compare the mean values of the parameters between the 2 groups. The χ on Human Research approved the study protocol, including the study assignment, purpose, subjects, periods, methods, and evaluation of the results. All patients provided written informed consent before enrollment.
RESULTS

Background:
The total number of subjects was 80 patients, including 61 males (76%) and 19 females (24%). The mean age was 61.6 ± 15.5 years, BMI was 23.7 ± 3.4 kg/m 2 , EF was 38.1 ± 16.4%, BNP was 241.7 ± 163.5 pg/mL, and AHI was 20.9 ± 16.9 /h (Table I) . Forty-eight patients (60.0%) from the study subjects had dilated cardiomyopathy (DCM) and 18 patients (22.5%) had an old myocardial infarction, 3 patients (3.8%) had hypertrophic cardiomyopathy (HCM), and 11 patients (13.7%) had other heart diseases. In the present study, 30 patients (37.5%) were prescribed an angiotensin converting enzyme (ACE) inhibitor, 42 patients (52.5%) an angiotensin II receptor blocker, 78 patients (97.5%) diuretics, 8 patients (10%) digoxin, and 31 patients (38.8%) a β-blocker. Patients with 5 ≧ AHI were defined as having SDB, and 66 (82.5%) of the study subjects had SDB. The prevalence of SDB in patients with ischemic heart failure or nonischemic heart failure was 88.2% and 80.6%, respectively, which revealed no significant difference. When the patients were divided into an EF < 40% group and an EF ≧ 40% group, the prevalence of SDB was 85.7% and 75.0%, respectively; thus indi- cating no significant difference. Prevalence of heart failure and clinical parameters: In the present study, AOT Figure 1 . AHI in each AOT group. Significant differences in AHI were observed between 6:00-12:00 and 0:00-6:00, between 6:00-12:00 and 18:00-24:00, between 12:00-18:00 and 0:00-6:00, and between 12:00-18:00 and 18:00-24:00 (P < 0.001, P < 0.0001, P < 0.001 and P < 0.001, respectively). AHI was significantly higher during the night than during the daytime.
Figure 2.
Relationship between AOT and prevalence of heart failure in the AHI ≧ 5 and AHI < 5 groups. When the patients were divided into an SDB (AHI ≧ 5) group and a non-SDB (AHI < 5) group, the number of patients in each AOT and the prevalence of heart failure were similar in the two groups. No significant differences were observed in the correlation between the two groups and their onset time categories.
could be identified in 59 patients (73.7%); 10% patients suffered from heart failure between 0:00 -6:00, 27.4% between 6:00 -12:00, 21.3% between 12:00 -18:00, and 15.0% between 18:00 -24:00. Meanwhile, 21 patients (26.3%) were unsure about their AOT and they had chronically exacerbated heart failure. Table I shows the characteristics of the patients in the 5 AOT groups. EF was significantly higher in patients between 12:00 -18:00 than 18:00 -24:00. Mean AHI was significantly higher in patients between 18:00 -24:00 and 0:00 -6:00 than between 6:00 -12:00 and 12:00 -18:00 (34.4 ± 14.2, 34.2 ± 19.8, 11.7 ± 12.6, and 11.5 ± 9.0, respectively, P = 0.0001; Figure 1) .
AOT in the severity of SDB: When the patients were divided into the SDB (AHI ≧ 5) group or non-SDB (AHI < 5) group, the number of patients in each AOT and the prevalence of heart failure were similar in the two groups (Figure 2 ). On the other hand, a statistically significant difference was observed when the patients were divided into the AHI ≧ 20 group or AHI < 20 group (Figure 3) . The prevalence of acute dyspnea between 24:00 -6:00 and between 18:00 -24:00 was 19% and 32% of the patients with AHI ≧ 20 and 4.1% and 4.1% of those with AHI < 20, indicating a significantly high occurrence between midnight and dawn in the patients with AHI ≧ 20. The same result was observed when the patients in unknown AOT were excluded from the evaluation. Table II shows the baseline characteristics of the patients in the AHI ≧ 20 and AHI < 20 groups. The OAI and CAI were significantly higher in the AHI ≧ 20 than AHI < 20 group (P = 0.02, P = 0.0001, respectively). No significant difference was observed in BMI, BNP, EF, or blood pressure on admission between the 2 groups.
DISCUSSION
Prevalence of SDB in patients with congestive heart failure: Patients with AHI ≧ 5 were defined as having SDB in the present study, and more than 80% of patients had SDB in this study population. When the cut-off point was set at AHI ≧ 15, 50% of the study subjects had SDB, which was similar to the results of previous studies conducted in western countries.
3,4) Sin, et al conducted a study on 450 patients with heart failure and reported that 33% of the patients in their study population had CSAS (AHI ≧ 10), which was similar to other study results that demonstrated approximately 40% of the patients with chronic heart failure had CSAS. [3] [4] [5] [6] In the present study, 33 (36.3%) of the patients with AHI ≧ 10 and 39 (48.8%) of those with AHI ≧ 5 had CSAS. Patients with congestive heart failure and AOT: A high occurrence of cardiovascular events, such as myocardial infarction and sudden death, in the early morning has been reported. 7, 8) Moser, et al 9) reported many cases of sudden death in patients with heart failure between 6:00 -12:00, which was 2.5 times higher than the other time periods, thus suggesting a morning surge in blood pressure due to increased sympathetic nerve activity might induce cardiovascular events. The current study results supported the results of previous studies, and 27.4% of our study subjects suffered from heart failure between 6:00 -12:00, which was 1.8 times higher than the other time periods. When the baseline characteristics of the patients between 6:00 -12:00 and those in the other time periods were compared, no significant difference was observed in EF, BNP at baseline, or blood pressure on admission. Accordingly, the severity of heart failure had no relation with the onset of acute dyspnea in the morning. This suggested that hypoxemia and heart strain due to elevated blood pressure along with increased sympathetic nerve activity might affect the onset of heart failure. In the present study, the peak onset time of acute dyspnea in severe SDB patients was between 18:00 -24:00, which was earlier than that of Moser, et al; accordingly, the elevated blood pressure and hypoxemia caused by SDB rather than increased sympathetic nerve activity following SDB might affect the onset of heart failure. SDB itself may play an important role. To date, no study has investigated the onset time of heart failure based on the SDB. Relationship between onset time and severity of SDB: The mean AHI of patients between 18:00 -24:00 and between 0:00 -6:00 was 34.4 ± 14.2 and 34.2 ± 14.2, respectively, which was higher than that of patients between 6:00 -12:00 (11.7 ± 12.6). The patients who suffered from heart failure between 18:00 -24:00 and 0:00 -6:00 had an AHI of 30 or greater; meanwhile, the patients between 6:00 -12:00 and 12:00 -18:00 had an AHI of about 10. Many patients with severe SDB had heart failure between midnight and dawn rather than during the daytime. Since the severity of heart failure had no influence on the onset mechanism, this result suggested that SDB might be one of the risk factors that induce heart failure during night.
Patients with severe SDB had decreased nocturnal and minimum oxygen saturation, intermittent arousal, and hypoxemia due to sleep apnea and increased sympathetic nerve activity, which resulted in heart strain due to elevated blood pressure. [10] [11] [12] SDB was related with heart strain due to apnea and various cardiovascular diseases. Some studies have reported a relationship between SDB and myocardial ischemia, 2, [13] [14] [15] arrhythmia, [16] [17] [18] sudden death, 19) platelet coagulation, 20) and inflammatory cytokines, 21, 22) all of which may trigger heart failure. These factors could therefore possibly cause heart failure between midnight and dawn. In the present study, more than 80% of the patients with congestive heart failure had SDB; no relationship was observed between AOT and SDB when the patients were divided into AHI < 5 or AHI ≧ 5 groups. When we divided the patients into an AHI < 20 group and an AHI ≧ 20 group, a relationship between AOT and SDB was observed; severe SDB might therefore affect the onset of heart failure. Further study will be necessary to elucidate the relationship between SDB and these factors. Study limitations: It was uncertain whether heart failure occurred during sleep or after awakening because the onset time of acute dyspnea was determined accord-ing to retrospective analysis based on clinical records. Normally, various factors, such as blood pressure, fatigue, infection, and medicine compliance affect the onset of heart failure. However, this study did not investigate the relationship between AOT and these factors. Further study is required to investigate these associations. Although the participants of this study were in clinically stable conditions after standard medical treatment, SDB still remained. Therefore, these results suggest that SDB may play a major role in the induction of heart failure. Clinical implications: In the present study, apnea was evaluated after treatment for heart failure. If apnea had been evaluated at the acute phase of heart failure, the severity of SDB would become greater. SDB treatment during the acute phase would possibly improve heart failure in the early stage, especially in patients with apnea which was related with the onset of cardiovascular events. In addition, the treatment of sleep apnea might be able to prevent the onset of acute dyspnea during the night in patients with chronic heart failure. Therefore, SDB treatment is indispensable not only to prevent heart failure but also to improve the prognosis of the patient. Physicians should make a correct diagnosis and provide adequate treatment for patients with SDB, since such actions may lead to an improvement of prognosis and quality of life. The present study results suggest that SDB treatment may reduce the onset of heart failure that occurs between midnight and dawn. Conclusion: This is the first study to report the relationship between AOT and sleep apnea. Patients with severe SDB had acute heart failure between midnight and dawn. The present findings suggest that sleep apnea may be a risk factor for heart failure during the night.
